Paper1376540
Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate.
Neyts J and 6 others. Virology, 1992. Cited by 135 papers, by iCite.
Cite this record
ConductScience Library. Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate. Papers, record 1376540. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1376540
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Membrane | Major topic |
| Cytomegalovirus | Major topic |
| Heparan Sulfate | Major topic |
| Polymers | Major topic |
| Virus Replication | Major topic |
| Acrylic Resins | |
| Animals | |
| CHO Cells | |
| Cells, Cultured | |
| Chondroitinases and Chondroitin Lyases | |
| Cricetinae | |
| Cyclodextrins | |
| Dextran Sulfate | |
| Glycosaminoglycans | |
| Heparin | |
| Heparin Lyase | |
| Humans | |
| Pentosan Sulfuric Polyester | |
| Polysaccharide-Lyases | |
| Sulfuric Acids | |
| Transcription, Genetic |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| GM33063 | NIGMS NIH HHS | United States | R01GM033063 | PubMed and NIH | NIH RePORTER |
| R37GM033063 | NIH | NIH RePORTER |
Cited by58
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 135 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38345384 | Human induced pluripotent stem cells are resistant to human cytomegalovirus infection primarily at the attachment level due to the reduced expression of cell-surface heparan sulfate. | J Virol | 2024 | https://conductscience.org/library/papers/38345384 | PubMed |
| 38259968 | Anti-herpes simplex virus activities and mechanisms of marine derived compounds. | Front Cell Infect Microbiol | 2023 | https://conductscience.org/library/papers/38259968 | PubMed |
| 37361103 | A Novel Vision of Reinforcing Nanofibrous Masks with Metal Nanoparticles: Antiviral Mechanisms Investigation. | Adv Fiber Mater | 2023 | https://conductscience.org/library/papers/37361103 | PubMed |
| 36986536 | Pentosan Polysulfate Affords Pleotropic Protection to Multiple Cells and Tissues. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/36986536 | PubMed |
| 35216019 | Polysaccharides and Their Derivatives as Potential Antiviral Molecules. | Viruses | 2022 | https://conductscience.org/library/papers/35216019 | PubMed |
| 34202941 | Evaluation of Microalgae Antiviral Activity and Their Bioactive Compounds. | Antibiotics (Basel) | 2021 | https://conductscience.org/library/papers/34202941 | PubMed |
| 34035845 | Cyclodextrins in the antiviral therapy. | J Drug Deliv Sci Technol | 2021 | https://conductscience.org/library/papers/34035845 | PubMed |
| 32866368 | Sustainable Personal Protective Clothing for Healthcare Applications: A Review. | ACS Nano | 2020 | https://conductscience.org/library/papers/32866368 | PubMed |
| 32121406 | Inhibition of Human Cytomegalovirus Entry into Host Cells Through a Pleiotropic Small Molecule. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32121406 | PubMed |
| 31561445 | Novel Antiretroviral Structures from Marine Organisms. | Molecules | 2019 | https://conductscience.org/library/papers/31561445 | PubMed |
| 27734286 | Developing Novel Antimicrobial and Antiviral Textile Products. | Appl Biochem Biotechnol | 2017 | https://conductscience.org/library/papers/27734286 | PubMed |
| 26321473 | Beyond RGD: virus interactions with integrins. | Arch Virol | 2015 | https://conductscience.org/library/papers/26321473 | PubMed |
| 26317854 | Role of Marine Natural Products in the Genesis of Antiviral Agents. | Chem Rev | 2015 | https://conductscience.org/library/papers/26317854 | PubMed |
| 25717110 | A role for 3-O-sulfated heparan sulfate in promoting human cytomegalovirus infection in human iris cells. | J Virol | 2015 | https://conductscience.org/library/papers/25717110 | PubMed |
| 24284427 | Antiviral Sulfoquinovosyldiacylglycerols (SQDGs) from the Brazilian brown seaweed Sargassum vulgare. | Mar Drugs | 2013 | https://conductscience.org/library/papers/24284427 | PubMed |
| 23856778 | A peptide inhibitor of cytomegalovirus infection from human hemofiltrate. | Antimicrob Agents Chemother | 2013 | https://conductscience.org/library/papers/23856778 | PubMed |
| 23235364 | The antiviral activities and mechanisms of marine polysaccharides: an overview. | Mar Drugs | 2012 | https://conductscience.org/library/papers/23235364 | PubMed |
| 21570424 | Early inhibitors of human cytomegalovirus: state-of-art and therapeutic perspectives. | Pharmacol Ther | 2011 | https://conductscience.org/library/papers/21570424 | PubMed |
| 19956628 | The Importance of Heparan Sulfate in Herpesvirus Infection. | Virol Sin | 2008 | https://conductscience.org/library/papers/19956628 | PubMed |
| 19576248 | Virucidal activity of polysaccharide extracts from four algal species against herpes simplex virus. | Antiviral Res | 2009 | https://conductscience.org/library/papers/19576248 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1376540
GET https://conductscience.org/api/papers/v1/1376540/cited_by?page=2